CN HEALTH TECH (01069): Xie Dongliang Appointed as Executive Director

date
20:17 29/09/2026
avatar
GMT Eight
China Health Technology Group (01069) announced that with effect from September 29, 2026: Ms. Siwanat Saymaya and Mr. Luo Tingzhuo have been appointed as members of the Company's Audit Committee, Remuneration Committee and Nomination Committee respectively; and Mr. Xie Dongliang has been appointed as the authorized representative of the Company under Rule 3.05 of the Listing Rules, while Mr. Liang Jiawei has ceased to act as the authorized representative of the Company under Rule 3.05 of the Listing Rules.
CN HEALTH TECH (01069) announces that with effect from September 29, 2026: Ms. Siwanat Saymaya and Mr. Luo Tingzhuo have been appointed as members of each of the Company's audit committee, remuneration committee and nomination committee; and Mr. Xie Dongliang has been appointed as the authorized representative of the Company under Rule 3.05 of the Listing Rules, and Mr. Liang Jiawei has ceased to act as the authorized representative of the Company under Rule 3.05 of the Listing Rules. With effect from the conclusion of the extraordinary general meeting: Ms. Bi Xue ceased to act as an executive director; Mr. Liang Jiawei ceased to act as an executive director; Ms. Huang Kaiying ceased to act as an executive director; Ms. Liu Shuhua ceased to act as an independent non-executive director; and Mr. Li Liangjie ceased to act as an independent non-executive director. The board further announces that with effect from the conclusion of the extraordinary general meeting: Mr. Xie Dongliang has been appointed as an executive director; Ms. Yang Linlin has been appointed as an executive director; Mr. Luo Tingzhuo has been appointed as an independent non-executive director; and Ms. Siwanat Saymaya has been appointed as an independent non-executive director.